Sun Life Financial Inc Abb Vie Inc. Transaction History

Sun Life Financial Inc

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$105.21 - $117.21 $336,040 - $374,368	-3,194 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$102.3 - $112.62 $13,810 - $15,203	135 Added 4.41%	3,194 $346,000
Q4 2020 Feb 11, 2021	SELL	$80.49 - $108.67 $268,836 - $362,957	-3,340 Reduced 52.2%	3,059 $328,000
Q3 2020 Nov 09, 2020	BUY	$85.91 - $100.83 $459,360 - $539,138	5,347 Added 508.27%	6,399 $560,000
Q2 2020 Aug 12, 2020	BUY	$73.37 - $98.18 $11,445 - $15,316	156 Added 17.41%	1,052 $103,000
Q1 2020 May 12, 2020	BUY	$64.5 - $97.79 $2,386 - $3,618	37 Added 4.31%	896 $68,000
Q4 2019 Feb 10, 2020	SELL	$72.13 - $90.25 $25,461 - $31,858	-353 Reduced 29.13%	859 $76,000
Q3 2019 Nov 13, 2019	BUY	$62.98 - $75.72 $1,133 - $1,362	18 Added 1.51%	1,212 $92,000
Q2 2019 Aug 08, 2019	SELL	$65.7 - $83.98 $86,724 - $110,853	-1,320 Reduced 52.51%	1,194 $87,000
Q1 2019 May 14, 2019	SELL	$77.14 - $90.79 $128,438 - $151,165	-1,665 Reduced 39.84%	2,514 $203,000
Q4 2018 Feb 06, 2019	BUY	$77.85 - $96.01 $1,790 - $2,208	23 Added 0.55%	4,179 $385,000
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $4,178 - $4,645	47 Added 1.14%	4,156 $393,000
Q2 2018 Aug 09, 2018	BUY	$89.78 - $106.23 $307,316 - $363,625	3,423 Added 498.98%	4,109 $381,000
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $1.73 Million - $2.32 Million	-18,793 Reduced 96.48%	686 $0
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $279,337 - $306,316	3,119 Added 19.06%	19,479 $1.88 Million
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $1.14 Million - $1.46 Million	16,360	16,360 $1.45 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Sun Life Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Sun Life Financial Inc with notifications on news.